This Saturday marks a year this PR: NuGenerex

New Post Public Reply Private Reply Replies (1) Message Board
docj Buildit #10470
367
This Saturday marks a year this PR:

NuGenerex Immuno-Oncology Spin-Out & Stock Dividend
Generex President & Chief Executive Officer Joe Moscato stated, “NuGenerex
Immuno-Oncology is being established to not only to advance the NuGenerex
Immuno-Oncology core technology, but also to expand the Company’s portfolio in
the field of immunotherapy and personalized medicine through partnerships and
acquisitions. As part of our strategy, we are exploring opportunities to spin-out
NuGenerex Immuno-Oncology as a separate DTC-eligible SEC registered
company. Mr. Moscato stated that following the spin-out, NuGenerex ImmunoOncology is expected to seek to list its common stock on a national stock
exchange. "The spin-out of NuGenerex Immuno-Oncology into a separate, publicly
Page 2 of 3
traded entity has been the focus of the Generex strategic development plan in
cancer drug development," Mr. Moscato indicated. "The Ii-Key technology has
been underappreciated for too long, as we have advanced the immunotherapy field
with the largest breast cancer vaccine study ever conducted, and now the results
of that trial have led to an exciting combination Phase II trial with AE37 plus
Ketruda in triple negative breast cancer. We believe this spin-out will help to
unlock the true value of the Ii-Key technology for our stockholders as it creates a
pure play in immunotherapy, which will foster investment and collaboration.”
The spin-out will be accomplished by the issuance of one or more dividends of
NuGenerex Immuno-Oncology stock to Generex stockholders. The record dates
in respect of such dividends are yet to be determined and will be announced in
due course. The stock dividends will enable Generex stockholders to directly
participate in the promising future of NuGenerex Immuno-Oncology as well as
create a large shareholder base with the potential for substantial liquidity on an
immediate basis. That liquidity will be further enhanced should NuGenerex
Immuno-Oncology be successful in attaining a national stock exchange listing, and
should provide NuGenerex Immuno-Oncology with ready access to the capital
markets to finance its on-going clinical and regulatory initiatives.
Following the issuance of stock dividends, Generex expects to retain a controlling
interest in NuGenerex Immuno-Oncology, but the exact proportion of the shares
to be held by Generex has not yet been determined.
Subject to market conditions and the satisfaction of regul

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 248

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 375

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 312

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 299

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Energy Management with ETB Controller from Energy Toolbase

Updated Category News Views 72

Energy Toolbase Reveals New Branding for Energy Management System Energy Toolbase has made a significant leap in the energy management sector by rebranding its energy storage control software, Acumen EMS™, to ETB Controller. This transformation marks a pivotal moment for the company as they strive to clarify the product's purpose and enhance user understanding. The ETB...

Continue Reading
FICO Achieves Silver Recognition in Analytics at 2024 IT Awards

Updated Category News Views 37

FICO Receives Silver Award for Analytics in 2024 IT Awards In a notable recognition of excellence, global analytics software leader FICO has earned the Silver Award in the Analytics category at the prestigious IT Awards for this year. Organized by Vogel IT-Media, these awards celebrate remarkable achievements and innovations within the IT sector, reflecting the industry's...

Continue Reading
Opera Limited Announces $0.40 Cash Dividend for Shareholders

Updated Category News Views 124

Opera Limited Announces Cash Dividend Opera Limited (NASDAQ: OPRA), a prominent developer in the browser market, has recently shared exciting news regarding its dividend program. The company’s Board of Directors has approved a semi-annual cash dividend of $0.40 per share. This dividend will be available to shareholders holding the company’s ordinary shares and...

Continue Reading
Revolutionizing IT Operations: JetPatch Unveils Version 5.0

Updated Category News Views 162

Revolutionizing IT Operations: JetPatch Unveils Version 5.0 New Capabilities Supercharge Patch Management and Streamline Enterprise Efficiency JetPatch, a leading innovator in enterprise IT operations, has revealed its most significant software release to date, which marks a major step forward in how organizations manage their servers, endpoints, and agents throughout...

Continue Reading
Revolutionizing Customer Billing: Ericsson and Wipro's Success

Updated Category News Views 97

Transformed Billing Experience for Odido Customers Ericsson (NASDAQ: ERIC) and Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) have successfully reshaped the billing landscape for Odido's mobile customers in the Netherlands. By adopting the cloud-native Ericsson Billing platform, hosted on Amazon Web Services (AWS), Odido can now offer cutting-edge 5G services along...

Continue Reading